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Original Article
Aims: There is limited knowledge about the association of lipoprotein particles and markers of coronary athero-
sclerosis such as coronary artery calcification (CAC) in relatively young high-risk persons. This study examines 
the association of lipoprotein subfractions and CAC in high cardiometabolic risk individuals.
Methods: The study presents analysis from baseline data of a randomized trial targeted at high-risk workers. 
Employees of Baptist Health South Florida with metabolic syndrome or diabetes were recruited. At baseline, all 
182 participants had lipoprotein subfraction analysis using the ion mobility technique and participants above 35 
years (N=170) had CAC test done. Principal components (PC) were computed for the combination of lipopro-
tein subclasses. Multiple bootstrapped regression analyses (BSA) were conducted to assess the relationship 
between lipoprotein subfractions and CAC.
Results: The study population (N=170) was largely female (84%) with a mean age of 58 years. Three PCs 
accounted for 88% variation in the sample. PC2, with main contributions from VLDL particles in the positive 
direction and large LDL particles in the negative direction was associated with a 22% increase in CAC odds (P 
value ＜0.05 in 100% of BSA). PC3, with main contributions from HDL lipoprotein particles in the positive 
direction and small/medium LDL and large IDL particles in the negative direction, was associated with a 9% 
reduction in CAC odds (P＜0.05 in 88% of BSA). PC1, which had approximately even contributions from 
HDL, LDL, IDL and VLDL lipoprotein subfractions in the positive direction, was not associated with CAC.
Conclusion: In a relatively young but high-risk population, a lipoprotein profile predominated by triglyceride-
rich lipoproteins was associated with increased risk of CAC, while one predominated by HDL lipoproteins offered 
modest protection. Lipoprotein sub-fraction analysis may help to further discriminate patients who require more 
intensive cardiovascular work-up and treatment.
economic burden of coronary disease, atherosclerotic 
CVD risk assessment is often conducted in asymp-
tomatic adults visiting their primary care providers in 
order to direct preventive care. Plasma low density lipo-
protein cholesterol (LDL-C), high density lipoprotein 
Introduction
Coronary artery disease remains a major cause of 
cardiovascular disease (CVD) morbidity and mortal-
ity. Due to the significant clinical, public health and 
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randomized trial comparing two internet based life-
style interventions for weight reduction and promo-
tion of cardiometabolic health. Participants were drawn 
from the employee population of Baptist Health South 
Florida (BHSF), a large not-for-profit health care orga-
nization in Miami, Florida. All study participants pro-
vided written informed consent. The study was approved 
by the BHSF institutional review board (IRB) (IRB 
13-028). This cross-sectional study presents findings 
based on data collected at baseline.
Study Population
To be included in the study, participants had to 
be current BHSF employees with high cardiometa-
bolic risk as defined as having metabolic syndrome or 
type Ⅱ diabetes mellitus. As per the National Choles-
terol Education Program (NCEP) guidelines, metabolic 
syndrome was defined as the presence of 3 or more of 
the following: waist circumference ＞40 inches in men 
and ＞35 inches in women; fasting triglyceride level 
≥150 mg/dl or on treatment, HDL-C ＜40 mg/dl in 
men or ＜50 mg/dl in women or on treatment, systolic 
blood pressure ＞130 mmHg or diastolic blood pres-
sure ＞85 mmHg or on treatment for hypertension and 
fasting blood glucose ≥100 mg/dl or on antidiabetic 
medication6).
We excluded persons who had a previous diagno-
sis of CVD or a history of a CVD event such as angina, 
myocardial infarction, prior coronary revascularization 
or stroke. We also excluded persons with heart failure, 
heart block, valvular disease, atrial fibrillation, and chr-
onic obstructive pulmonary disease (COPD). Women 
of child-bearing potential who were pregnant or seek-
ing to become pregnant were also excluded, as were 
women with a history of bilateral mastectomy. Sub-
jects receiving active treatment for cancer or those 
who had undergone a computerized tomography scan 
of the chest within the last 1 year were also excluded.
Study Measurements
At baseline, all participants completed question-
naires on demographic and socioeconomic character-
istics and lifestyle behaviors. The demographic infor-
mation collected included age, sex, ethnicity, family 
income, level of education and family size. Dietary 
pattern was assessed using a modified version of a vali-
dated Mediterranean Diet questionnaire7). Physical activ-
ity was assessed using the Global Physical Activity Ques-
cholesterol (HDL-C) and triglycerides are tradition-
ally used to assess dyslipidemic burden and guide CVD 
risk assessment and management. However, the use of 
traditional lipids in CVD risk assessment is flawed by 
its inability to identify young persons and women with 
high atherosclerotic burden and thus missing early treat-
ment opportunities in these individuals1).
Non-invasive measures of coronary atherosclero-
sis such as coronary artery calcification (CAC) have 
prognostic significance, are useful in cardiovascular dis-
ease risk stratification and are included in the guide-
lines for CVD risk assessment among persons with inter-
mediate global risk scores2). Coronary atherosclerotic 
burden as measured by CAC correlates well with CVD 
risk. In particular, persons with CAC scores (Agatston 
Units) of zero have been shown to have very low mor-
tality risk3, 4).
Several lipoprotein subfractions have been dem-
onstrated to be associated with atherosclerotic CVD 
events including mortality. However, the role of lipo-
protein subfractions in CVD risk assessment is still not 
clearly defined particularly among relatively young (less 
than 60 years) high cardiometabolic risk individuals. 
Several studies have described a lipoprotein profile that 
is thought to account for the most atherosclerotic CVD 
risk5). Although this atherogenic lipoprotein profile has 
been demonstrated to be associated with CVD events, 
the relationship between lipoprotein subclasses and non-
invasive measures of coronary artery atherosclerosis such 
as coronary artery calcium has only been examined by 
a handful of studies. In most of these studies, even 
though the relationship of individual lipoprotein sub-
fractions are examined, their significant inter-correla-
tion is often not accounted for and the combinations 
identifying atherosclerosis risk is rarely examined.
In this study, we assessed the relationship between 
individual lipoprotein subfractions, as measured by ion 
mobility analysis, and coronary artery calcification in 
a relatively young employee population with high car-
diometabolic risk. First, we examined the association 
of individual lipoprotein subfractions with the pres-
ence of CAC. Next, we explored combinations of lipo-
proteins, as identified in a principal component analy-
sis, and their associations with CAC.
Methods
The Baptist Employee Healthy Heart Study is a 
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and used in several large scale cohort studies11, 12). The 
total cholesterol, HDL-C and triglycerides were mea-
sured by spectrophotometry, while the LDL-C was cal-
culated using the Friedewald formula13) unless triglyc-
eride levels were greater than 400 mg/dl.
Participants who were above the age of 35 years 
also had CT scan for coronary artery calcium quanti-
fication. Coronary arteries were scanned by non-con-
trast multi-detector row CT (acquisition time: 100 ms, 
3 mm slice thickness) during the end-diastole. CAC 
score was determined by the Agatston method14).
Statistical Analysis
Nonparametric Spearman rank correlation coef-
ficients were quantified for combinations of lipopro-
teins and lipids (HDL-C, LDL-C and triglycerides). A 
principal component analysis was conducted for lipo-
protein subfractions with and without the lipids for 
170 individuals who had complete data on both lipo-
proteins and CAC. Principal component analysis is a 
statistical procedure that transforms possibly corre-
lated variables such as lipoprotein subfractions into 
linear uncorrelated variables. This analyses effectively 
reduces the dimensions of the data while preserving 
most of the information within the data. Principal 
component analysis is a statistical procedure that trans-
forms possibly correlated variables such as lipoprotein 
subfractions into linear uncorrelated variables. This 
analyses effectively reduces the dimensions of the data 
while preserving most of the information within the 
data. Principal component analysis generates eigenvec-
tors (often called principal component vectors) and 
their corresponding eigenvalues (a measure of variance) 
that are ranked in descending order of the amount of 
tionnaire8). Participants also responded to questions 
on their past medical, social and family history.
All participants had their weights measured on a 
calibrated weight scale, without shoes and with empty 
pockets. Height was measured with a standardized scale 
(Seca 213 Portable Stadiometer, Seca GmbH & Co. 
KG, Hamburg, Germany) also without shoes. Partici-
pant abdominal circumference was measured using a 
gulick measuring tape and according to the National 
Institutes of Health (NIH) protocol. The gulick tape 
was placed at a horizontal plane around the abdomen 
at the level of the iliac crest with tension applied and 
the measurement was taken at the end of expiration. 
Blood pressure was measured in a seating position 5 
minutes after rest following the guidelines of the Amer-
ican Heart Association9).
Blood draw for laboratory samples for the lipo-
protein analysis were conducted after an 8 hour fast. 
At the study site, a total of about 28 mls of blood were 
drawn in 5 tubes (2.7 mls in citrate plasma tube, 17 
mls in 2 serum separator tubes and 8 mls in 2 ethyl-
enediaminetetraacetate tubes). Samples for lipoprotein 
subfraction analysis were centrifuged at room temper-
ature (15-25℃) for 15 minutes at 3,000 rpm and ali-
quots of 1.5 mls of serum were placed in standard 
transfer tubes. Aliquots were stored at －60℃ to －90℃ 
and shipped monthly to an American College of Pathol-
ogy-certified laboratory (Quest Diagnostics Nichols 
Institute, San Juan Capistrano, CA) on dry ice. Lipo-
protein subfraction analysis was conducted using the 
gas-phase differential electrical mobility (ion mobility) 
analysis which directly quantifies the full spectrum of 
lipoprotein particles. The ion mobility technique is 
described elsewhere10). This method has been validated 
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repeated 1000 times. The mean odds ratio (OR) and 
the mean 95% confidence interval (CI), as well as the 
frequency of a p value ＜0.05 are reported. Covariates 
included in the regression analysis were age, sex, BMI, 
hypertension, diabetes, diet-score, cigarette smoking, 
non-HDL-C, physical activity. A statistical significance 
level of alpha=0.05 was chosen. Bootstrapping is a 
statistical method in which the data is resampled with 
replacement repeatedly generating multiple bootstrap 
samples (in this case 5000)16, 17). Considering that the 
study sample size is small, a bootstrapped analysis is a 
reliable way to increase power16). Our method of con-
ducting repeated regression analysis on bootstrapped 
samples allows for more accurate estimates of statisti-
cal significance and has been used in previous stud-
ies18). This method also provides for precise confidence 
intervals16).
All statistical analyses were conducted in STATA 
version 12 (StataCorp LP, College Station, TX)19) and 
SAS version 9.4 (SAS Institute, Cary, NC)20).
Results
A total of 182 participants were recruited at base-
line and participated in this study. Of these, 12 partic-
ipants, who were 35 years or younger and did not have 
data variation explained. From the principal compo-
nent vectors the coefficients of the linear transforma-
tion (loading values) for each individual within a prin-
cipal component was computed. Principal component 
scores for each individual were then calculated as the 
summation of the product of the coefficients and the 
particle concentration minus the lipid/lipoprotein sub-
fraction mean for each lipid or subfraction15). Supple-
mentary Figs.1-3 shows the scree and variance plots, 
loading plots and the score plots. The scree plot is a 
graph of the eigenvalues for each principal component 
while the variance plot is a graph of the variance 
explained by each principal component. The loading 
plots show the contribution of each lipid /lipoprotein 
subfractions to the principal components while the 
score plot shows the contribution of each observation, 
represented by a score, to each principal component.
We then bootstrapped our sample size of 170 to 
5000 with replacement. Using an adjusted multivari-
ate logistic regression analysis, the three principal com-
ponents that accounted for the most variance were 
then assessed for their relationship with CAC presence 
(CAC ＞0). Similarly, the relationship of HDL-C, LDL-
C, triglycerides and each lipoprotein subfraction was 
examined also adjusting for earlier outlined covariates. 
The regression analysis of bootstrapping samples was 
Table 2. Spearman correlation coefficients (ρ) for lipid and lipoprotein measures
HDL-C LDL-C Trig HDL-S HDL-L LDL-VS LDL-S LDL-M LDL-La LDL-Lb IDL-S IDL-L VLDL-S VLDL-M VLDL-L
HDL-C 1.0 0.18a －0.29c 0.30d 0.52d－0.24a －0.20a 0.10 0.48d 0.36d 0.47d 0.07 －0.02 －0.29c －0.30c
LDL-C 1.0 0.05 0.25b 0.16a 0.19a 0.38d 0.60d 0.54d 0.56d 0.61d 0.62d 0.55d 0.22b 0.09
Trig 1.0 0.08 －0.01 0.47d 0.44d－0.02 －0.38d－0.30c －0.13 0.34d 0.52d 0.84d 0.83d
HDL-S 1.0 0.75d 0.52d 0.48d 0.57d 0.53d 0.54d 0.64d 0.61d 0.53d 0.38c 0.08
HDL-L 1.0 0.29c 0.18a 0.64d 0.32d 0.44d 0.62d 0.44d 0.39d 0.22 0.12
LDL-VS 1.0 0.79d 0.62d－0.05 0.00 0.16a 0.50d 0.50d 0.57d 0.42d
LDL-S 1.0 0.69d 0.07 0.23d 0.29c 0.62d 0.55d 0.53d 0.37d
LDL-M 1.0 0.67d 0.82d 0.64d 0.60d 0.44d 0.23d 0.08
LDL-La 1.0 0.95d 0.85d 0.39c 0.29 －0.09 －0.17a
LDL-Lb 1.0 0.79d 0.44d 0.28c －0.01 －0.15
IDL-S 1.0 0.70d 0.55d 0.17 0.00
IDL-L 1.0 0.90d 0.62d 0.41d
VLDL-S 1.0 0.80d 0.62d
VLDL-M 1.0 0.92d
VLDL-L 1.0
aP＜0.05, bP＜0.01, cP＜0.001, dP＜0.0001
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tions and the large LDL lipoprotein subfractions were 
negatively correlated with CAC, albeit weakly (Sup-
plementary Table 2)
Table 3 shows the median lipid and lipoprotein 
particle concentrations for those with CAC=0 and CAC 
＞0. Higher concentrations of large LDL were seen 
among those with no CAC. Persons without CAC also 
had lower triglyceride and higher HDL particle con-
centrations, though statistical comparisons show that 
these differences were only marginally significant. In 
trend analyses comparing median lipoprotein subclasses 
across groups of CAC=0, CAC=1-99 and CAC=100 
or more (Supplementary Table 3), there was a trend 
to increasing median triglycerides and decreasing large 
LDL subfractions and decreasing HDL lipoprotein 
subfractions with increasing CAC.
Results of the principal component (PC) descrip-
tions are shown in Table 4 and are graphically described 
in the Supplementary Figs.1-3. As shown in the scree 
and variance plots (Supplementary Fig.1) and in Table 
4, the first three principal components accounted for 
more than 80% of the variance in the data. The con-
tributions to PC1 were more evenly split across lipo-
protein particle groups with slightly greater contribu-
tions from the small and medium LDL particles, the 
small and large IDL particles and the small VLDL 
particles. The major contributions of PC2 were VLDL 
particle in the positive direction and the large LDL 
particles in the negative direction, while PC3 repre-
a CAC scan done, were excluded. The study popula-
tion consisted of 170 participants with a mean age of 
58 years, mostly female (84%) and with a high fre-
quency of hypertension (85%). Participants with CAC 
＞0 were older and had a higher frequency of males 
and cigarette smokers. Diabetes was also more com-
mon among persons with CAC ＞0. More details about 
population characteristics can be found in Table 1 and 
in Supplementary Table 1. Description on the distri-
bution of the lipid and lipoprotein particles are shown 
in the box plots in Supplementary Fig.4.
Table 2 shows the non-parametric spearman cor-
relation coefficients (ρ) comparing lipids and lipopro-
tein subfractions to each other. The strongest correla-
tions with triglycerides were the VLDL particles (ρ=  
0.52, 0.84, 0.83 for the small, medium and large respec-
tively). The very small and small LDL lipoproteins were 
also strongly correlated with triglycerides (ρ=0.47, 0.44). 
Notably, the large LDL particles (subfractions a and b 
respectively) were inversely correlated with triglycerides 
(ρ=－0.38, －0.30) but were strongly correlated with 
HDL-C (ρ=0.48, 0.36), and with both the small HDL 
(ρ=0.53, 0.54) and large HDL (ρ=0.32, 0.44) lipopro-
tein particles. The strongest correlations of the HDL-C 
were with the HDL-L (ρ=0.52), both subfractions of 
LDL large (0.48, 0.36 for a and b respectively) and 
IDL-S (ρ=0.47). In non-parametric correlation anal-
ysis (spearman’s), triglycerides were weakly positively 
correlated with CAC, while HDL lipoprotein subfrac-



































































All values are medians (interquartile ranges) unless otherwise stated.
LDL-C Low density lipoprotein cholesterol; LDL Low density lipoprotein; HDL-C High-density lipoprotein cholesterol; 
HDL High-density lipoprotein cholesterol; IDL Intermediate-density lipoprotein, VLDL very-low-density lipoprotein;
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exhibit much variation in lipoprotein subclasses and 
was not associated with CAC. Each SD increase in PC2, 
representing decreased medium and large LDL lipo-
protein particles, increased VLDL and small LDL lipo-
protein particles, and increased triglycerides, was asso-
ciated with a 22% increase in the odds of CAC. On 
the other hand, a each SD increase in PC3, a combi-
nation of increasing small and large HDL particles and 
decreasing small and medium LDL particles, was asso-
ciated with a 9% reduction in the odds of CAC. Musun-
uru and colleagues, using a principal component anal-
yses method in the Malmö diet and Cancer-Cardio-
vascular Cohort (MDC-CC) demonstrated that a pat-
tern with increased small and medium LDL particle 
concentrations, decreased large HDL particle concen-
trations and increased triglyceridemia (referred to as ath-
erogenic dyslipidemia)12, 21). PC2's profile is similar to 
the atherogenic lipoprotein profile described by Musun-
uru et al., a profile demonstrated to be associated with 
increased atherosclerotic cardiovascular disease mortal-
ity risk22).
A previous study, using the concept of a principal 
component analysis, identified three separate axes of 
cardiovascular risk. In that study, the authors demon-
strated that a principal component axis that comprised 
mainly of contributions from increasing VLDL and 
LDL particles, as well as another PC axis in which small 
and medium LDL particles combined with diminish-
ing (negative direction) large HDL, was associated with 
increased risk of CV events12). In a separate study, a 
PC axis characterized by contributions from VLDL in 
sents HDL lipoprotein particles in the positive direc-
tion and small and medium LDL particles as well as 
large IDL particles in the negative direction. Addition 
of HDL-C, LDL-C and triglycerides altered the con-
tribution of the large IDL to PC3 but did not signifi-
cantly alter the other PC patterns. The loading plots 
(Supplementary Fig.2) show the relative lipoprotein 
contributions and their directions as described above.
In multivariate boot-strapped analysis, control-
ling for earlier mentioned covariates, there was no asso-
ciation between PC1 and the presence of CAC. PC2 
was associated with a 22% increase in the odds of 
CAC (OR 1.22, 95% CI: 1.17-1.27, p＜0.05 in 100% 
of boot-strapped analysis) while PC3 showed a mod-
est but significant reduction in CAC odds (OR 0.91, 
95% CI: 0.85-0.97, p＜0.05 in 88% of boot-strapped 
analysis). Analysis of the cholesterol and lipoprotein 
particles showed that the large LDL particles were pro-
tective of CAC, and the small and medium LDL were 
associated with greater odds for the presence of CAC. 
Notably, LDL-C did not show an association with CAC.
Discussion
In this study of 170 relatively young individuals 
with high cardiometabolic risk, two of the three prin-
cipal component axes (accounting for about 88% of 
the variance) of lipoprotein distribution were associ-
ated with the presence of CAC, even after controlling 
for traditional cardiovascular risk factors. Although PC1 
accounted for nearly 60% of the variance, PC1 did not 
Table 4. Description of Principal Components
Measure
Principal Components with Lipoprotein only Principal Components with Lipoproteins and Lipids
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and non-diabetic individuals26). In contrast, HDL lipo-
protein exerts its anti-atherogenic effect through exer-
tion multiple anti-oxidant mechanisms and promo-
tion of efflux of excess cholesterol from foam cells in 
the arterial wall27). Thus, it is conceivable that a lipo-
protein profile predominated by increased HDL parti-
cles appears protective of CAC.
Ion mobility analysis for the subfractionation of 
lipoproteins employs a gas-phase chromatography sys-
tem that directly counts the lipoprotein particles10). Lipo-
protein subfractionation using the ion mobility analy-
sis has been used in other large studies11, 12) and holds 
the advantage of directly assessing particle counts with-
out the use of an algorithm10). To our knowledge, this 
is the first study using ion-mobility analysis that iden-
tifies CAC risk by lipoprotein profile.
As noted in the results, the individual lipoprotein 
subfractions are correlated in varying degrees both 
within classes (e.g. HDL lipoprotein subfractions being 
correlated) and between classes (e.g. HDL lipoprotein 
subfractions with LDL subfractions, Table 3). There-
fore, analysis of individual subfractions without con-
text to the others poses a dilemma with interpretation 
of results (Table 2). To circumvent this, we conducted 
principal component analyses. Principal component 
the positive direction and large LDL particles in the 
negative direction was associated with incident CAC 
in persons with CKD23). Our study showed similar 
results with the aforementioned studies, with an axis 
of CAC risk defined by the combination of VLDL 
particles and diminishing large LDL particles (i.e. in 
the negative direction). We also demonstrated modest 
protection with a PC axis that combined increasing 
HDL particles with diminishing LDL particles. In a 
search of the published literature, we did not find any 
other studies that had examined lipoproteins and their 
association with CAC in terms of axis of risk in rela-
tively young patients with high cardiometabolic risk 
but otherwise healthy.
PC2 represents an axis of risk that is character-
ized by high triglyceride rich lipoproteins (TGRL) i.e. 
VLDL combined with low levels of large LDL parti-
cles. TGRLs are proinflammatory, leading to athero-
sclerosis by pathways that involve the upregulation of 
TNF-alpha, induction of vascular cell adhesion mole-
cules (VCAM) and promotion of monocyte infiltra-
tion of the vessel wall24). TGRLs have been associated 
with risk of ASCVD, ASCVD-related mortality and 
all-cause mortality25). Elevated VLDL has also been 
associated with the presence of CAC in both diabetic 
Table 5. Boost Strapped Analysis for Odds ratio of CAC 
Principal Components Boot Strapped N











































































Sample bootstrapped to size of 5000. Regression analysis conducted 1000 times. OR and CIs is calculated as the mean of OR and 
their upper and lower CI limits from 1000 bootstrapped analysis.
% with P＜0.05 is the frequency of OR that have P＜0.05 out of analysis conducted 1000 times.
Controlled for age, sex, blood pressure, presence of diabetes, cigarette smoking, diet and physical activity. All lipoproteins were 
included in regression models for the individual lipoproteins.
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Supplementary Fig.1. Scree and Variance Plots of Principal Components
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Supplementary Fig.2. Loading plots for PC 1, PC 2 and PC 3
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Supplementary Fig.3. Score plots for PC 1, PC 2 and PC 3
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Supplementary Fig.4. Box plots of lipoprotein subclasses
Supplementary Table 2. Correlation of CAC with Lipids and Lipoprotein subfractions
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Supplementary Table 3. Relationship CAC and Lipoproteins
Variable
CAC=0
(N=88)
CAC 1-99
(N=50)
CAC 100＋
(N=32)
P trend
LDL-c (mg/dL)
HDL-c (mg/dL)
Triglycerides (mg/dL)
LDL-VS (nmol/L)
LDL-S (nmol/L)
LDL-M (nmol/L)
LDL-La (nmol/L)
LDL-Lb (nmol/L)
IDL-S (nmol/L)
IDL-L (nmol/L)
HDL-L (nmol/L)
HDL-S (nmol/L)
VLDL-S (nmol/L)
VLDL-M (nmol/L)
VLDL-L (nmol/L)
128 (103–151)
47 (41 –57)
124 (95 –168)
415 (301–632)
266 (191–392)
286 (232–383)
270 (220–393)
247 (182–317)
224 (175–274)
200 (151–255)
6675 (5928 –8301)
21655 (19962 –25815)
71 (56 –94)
56 (43 –94)
16 (9–33)
115 (97 –140)
48 (41–54)
140 (92 –172)
402 (341–592)
258 (203–322)
262 (220–356)
253 (183–353)
223 (163–301)
186 (144–259)
177 (141–214)
6345 (5700 –7880)
20832 (18570 –24913)
61 (48–81)
56 (32–76)
15 (6–27)
123 (98 –142)
42 (38–49)
164 (118–237)
506 (352–749)
311 (217–410)
278 (222–357)
231 (184–330)
197 (157–283)
192 (159–243)
190 (163–251)
6142 (5597 –7340)
20449 (18266–23961)
70 (59–86)
68 (43–91)
21 (11–35)
0.172
0.065
0.016
0.126
0.217
0.413
0.013
0.036
0.036
0.771
0.047
0.047
0.825
0.548
0.685
